- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
BCL-2 as therapeutic target for hematological malignancies ; volume:11 ; number:1 ; day:11 ; month:5 ; year:2018 ; pages:1-15 ; date:12.2018
Journal of hematology & oncology ; 11, Heft 1 (11.5.2018), 1-15, 12.2018
- Creator
-
Perini, Guilherme Fleury
- Contributor
-
Ribeiro, Glaciano Nogueira
Pinto Neto, Jorge Vaz
Campos, Laura Tojeiro
Hamerschlak, Nelson
SpringerLink (Online service)
- DOI
-
10.1186/s13045-018-0608-2
- URN
-
urn:nbn:de:101:1-2018071518461616448089
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Perini, Guilherme Fleury
- Ribeiro, Glaciano Nogueira
- Pinto Neto, Jorge Vaz
- Campos, Laura Tojeiro
- Hamerschlak, Nelson
- SpringerLink (Online service)
Other Objects (12)
Combination of BCL-2 inhibitors and immunotherapy: a promising therapeutic strategy for hematological malignancies
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
Deubiquitinases in hematological malignancies
Natural and synthetic compounds modulating targets associated with hematological malignancies
The role of proteostasis in hematological malignancies and the therapeutic implications
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
Rac GTPases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Combination of BCL-2 inhibitors and immunotherapy: a promising therapeutic strategy for hematological malignancies
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
Deubiquitinases in hematological malignancies
Natural and synthetic compounds modulating targets associated with hematological malignancies
The role of proteostasis in hematological malignancies and the therapeutic implications
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
Rac GTPases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Combination of BCL-2 inhibitors and immunotherapy: a promising therapeutic strategy for hematological malignancies
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
Deubiquitinases in hematological malignancies
Natural and synthetic compounds modulating targets associated with hematological malignancies
The role of proteostasis in hematological malignancies and the therapeutic implications
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
Rac GTPases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism